NDC 51662-1402-01 - DOXY 100(TM) DOXYCYCLINE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51662-1402
- Requested NDC
- 51662-1402-01
- Package NDCs from labels
- 51662-1402-1, 51662-1402-2, 51662-1402-3, 51662-1402-01
- Manufacturer
- HF Acquisition Co LLC, DBA HealthFirst
- Effective date
- 2024-01-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| DOXY 100(TM) DOXYCYCLINE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-01-30 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51662-1402-1 | DOXY 100(TM) DOXYCYCLINE | 10 mL in 1 VIAL | INJECTION, POWDER, LYOPHILIZED, | 10 | 4 | |
| 51662-1402-2 | DOXY 100(TM) DOXYCYCLINE | 1 in 1 POUCH | INJECTION, POWDER, LYOPHILIZED, | 1 | 4 | |
| 51662-1402-2 | DOXY 100(TM) DOXYCYCLINE | 10 mL in 1 VIAL | INJECTION, POWDER, LYOPHILIZED, | 10 | 4 | |
| 51662-1402-3 | DOXY 100(TM) DOXYCYCLINE | 10 in 1 BOX | INJECTION, POWDER, LYOPHILIZED, | 10 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51662-1402 | DOXY 100(TM) DOXYCYCLINE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HF ACQUISITION CO LLC, DBA HEALTHFIRST] | 4 | Current NDC, Legacy NDC, 4 package rows | 20240201_9454f948-584f-59de-e053-2a95a90a9f01.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Novel Laboratories, Inc. | 25a92544-1421-4ccb-a49c-11742851f214 | 2018-03-12 | Warnings, Adverse reactions | 19XTS3T51U |
| Immuno Fortifier | ECHINACEA (ANGUSTIFOLIA), HYDRASTIS CANADENSIS, LIGUSTICUM PORTERI, MYRRHA, NASTURTIUM AQUATICUM, TABEBUIA IMPETIGINOSA, TRIGONELLA FOENUM-GRAECUM, ASCORBIC ACID, PINUS SYLVESTRIS, LYMPH (SUIS), MEDULLA OSSIS SUIS, SPLEEN (SUIS), THYMUS (SUIS), HEPAR SULPHURIS CALCAREUM, PHOSPHORICUM ACIDUM, SILICEA | BioActive Nutritional, Inc. | 04024663-0b11-438a-a21a-8e86edd8052a | 2018-01-15 | Warnings | PQ6CK8PD0R |
| Acticlate CAP | DOXYCYCLINE HYCLATE | Aqua Pharmaceuticals | 5e96d473-63dd-4446-88cf-eef2cd3339f0 | 2017-11-28 | Warnings, Adverse reactions | 19XTS3T51U |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.